Immunization safety review :: thimerosal-containing vaccines and neurodevelopmental disorders /
Gespeichert in:
| Körperschaft: | |
|---|---|
| Weitere Verfasser: | , , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academy Press,
©2001.
|
| Schriftenreihe: | Compass series (Washington, D.C.)
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (xiii, 122 pages :) |
| Format: | Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 0309565731 9780309565738 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocm57005524 | ||
| 003 | OCoLC | ||
| 005 | 20240705115654.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 041120s2001 dcuad ob 000 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d YDXCP |d OCLCQ |d MMU |d BAKER |d LVB |d REDDC |d OCLCE |d OCLCQ |d IDEBK |d COF |d OCLCQ |d MERUC |d CCO |d E7B |d GPM |d DKDLA |d NNM |d SNM |d OCLCQ |d XFF |d FVL |d OCLCQ |d OCLCO |d OCLCQ |d NLGGC |d OCLCQ |d UV0 |d EBLCP |d OCLCQ |d AZK |d LOA |d OCLCO |d OCLCA |d TOA |d OCLCO |d MOR |d PIFBR |d ZCU |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d NJR |d OCLCA |d AGLDB |d OCLCA |d U3W |d BUF |d OCLCO |d OCLCQ |d OCLCO |d OCLCF |d OCLCO |d STF |d VNS |d WRM |d OCLCO |d OCLCQ |d VTS |d OCLCO |d COCUF |d NRAMU |d EZ9 |d ICG |d VT2 |d AU@ |d OCLCQ |d OCLCO |d WYU |d OCLCA |d G3B |d DKC |d OCLCO |d OCLCQ |d OCLCO |d MERER |d OCLCO |d CEF |d OCLCQ |d OCLCO |d ADU |d KIJ |d OCLCQ |d K6U |d OCLCA |d UKCRE |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCQ |d OCLCL |d SFB | ||
| 015 | |a GBA376785 |2 bnb | ||
| 019 | |a 48972074 |a 49604899 |a 70752236 |a 475754481 |a 488338610 |a 559521597 |a 606676038 |a 609216218 |a 646723489 |a 666925644 |a 722312199 |a 728011803 |a 756529205 |a 767450788 |a 771300093 |a 923268733 |a 961559357 |a 962587840 |a 966261309 |a 988482525 |a 991915290 |a 1011897732 |a 1017612098 |a 1018027318 |a 1028767577 |a 1037900777 |a 1038185333 |a 1038668518 |a 1044634997 |a 1045387444 |a 1045485320 |a 1047574288 |a 1055377160 |a 1065042781 |a 1103541314 |a 1112872373 |a 1119150538 |a 1119441577 |a 1153535487 |a 1204384453 |a 1228582382 | ||
| 020 | |a 0309565731 |q (electronic bk.) | ||
| 020 | |a 9780309565738 |q (electronic bk.) | ||
| 020 | |z 0309076366 | ||
| 020 | |z 9780309076364 | ||
| 020 | |z 0309090083 |q (pbk.) | ||
| 020 | |z 9780309090087 |q (pbk.) | ||
| 035 | |a (OCoLC)57005524 |z (OCoLC)48972074 |z (OCoLC)49604899 |z (OCoLC)70752236 |z (OCoLC)475754481 |z (OCoLC)488338610 |z (OCoLC)559521597 |z (OCoLC)606676038 |z (OCoLC)609216218 |z (OCoLC)646723489 |z (OCoLC)666925644 |z (OCoLC)722312199 |z (OCoLC)728011803 |z (OCoLC)756529205 |z (OCoLC)767450788 |z (OCoLC)771300093 |z (OCoLC)923268733 |z (OCoLC)961559357 |z (OCoLC)962587840 |z (OCoLC)966261309 |z (OCoLC)988482525 |z (OCoLC)991915290 |z (OCoLC)1011897732 |z (OCoLC)1017612098 |z (OCoLC)1018027318 |z (OCoLC)1028767577 |z (OCoLC)1037900777 |z (OCoLC)1038185333 |z (OCoLC)1038668518 |z (OCoLC)1044634997 |z (OCoLC)1045387444 |z (OCoLC)1045485320 |z (OCoLC)1047574288 |z (OCoLC)1055377160 |z (OCoLC)1065042781 |z (OCoLC)1103541314 |z (OCoLC)1112872373 |z (OCoLC)1119150538 |z (OCoLC)1119441577 |z (OCoLC)1153535487 |z (OCoLC)1204384453 |z (OCoLC)1228582382 | ||
| 037 | |n Title subscribed to via ProQuest Academic Complete | ||
| 042 | |a dlr | ||
| 050 | 4 | |a RA638 |b .I648 2001eb | |
| 060 | 4 | |a 2001 O-342 | |
| 060 | 4 | |a WS 135 |b I333 2001 | |
| 072 | 7 | |a MED |x 076000 |2 bisacsh | |
| 072 | 7 | |a MED |x 030000 |2 bisacsh | |
| 072 | 7 | |a MED |x 078000 |2 bisacsh | |
| 082 | 7 | |a 614.5/98 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Immunization safety review : |b thimerosal-containing vaccines and neurodevelopmental disorders / |c Kathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. |
| 246 | 3 | 0 | |a Thimerosal-containing vaccines and neurodevelopmental disorders |
| 260 | |a Washington, D.C. : |b National Academy Press, |c ©2001. | ||
| 300 | |a 1 online resource (xiii, 122 pages :) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 490 | 1 | |a The compass series | |
| 504 | |a Includes bibliographical references. | ||
| 588 | 0 | |a Print version record. | |
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 505 | 0 | |a IMMUNIZATION SAFETY REVIEW -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- PLAUSIBILITY ASSESSMENT -- Biological Plausibility -- Causality -- SIGNIFICANCE ASSESSMENT -- PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Research -- Clinical Research -- Basic Science Research -- Communications -- SUMMARY -- REFERENCES -- Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders -- ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT | |
| 505 | 8 | |a THE CHARGE TO THE COMMITTEETHE STUDY PROCESS -- THE FRAMEWORK FOR ASSESSING CAUSALITY -- UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS -- Thimerosal in Vaccines -- Neurodevelopmental Disorders -- Autism -- Attention Deficit/Hyperactivity Disorder (ADHD) -- Speech or Language Delay -- PLAUSIBILITY ASSESSMENT -- Evidence Regarding Association: Biological Plausibility -- Mercury Toxicokinetics -- Comparisons of Ethylmercury and Methylmercury -- Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury | |
| 505 | 8 | |a Health Effects of Low-Dose Exposures to Thimerosal and MethylmercuryInvestigations Related to Mercury and Heavy Metals in Children with Autism -- Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines -- Biological Plausibility Argument -- Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies -- Case Reports and Case Series -- Epidemiological Studies -- CAUSALITY ARGUMENT -- SIGNIFICANCE ASSESSMENT -- Concern Regarding Neurodevelopmental Disorders | |
| 505 | 8 | |a Continued Exposure to ThimerosalUse of Thimerosal-Containing Vaccines in Other Countries -- Confusion from Changes in Hepatitis B Immunization Policy -- Trust in the Safety of Vaccines -- Conclusion -- RECOMMENDATIONS REGARDING THE PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Studies -- Clinical Studies -- Basic Science Studies -- Communications -- SUMMARY -- REFERENCES -- Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary | |
| 505 | 8 | |a OVERVIEW OF THE IMMUNIZATION SAFETY REVIEW PROJECTTHE HYPOTHESIZED RELATIONSHIP BETWEEN MMR AND AUTISM -- PLAUSIBILITY ASSESSMENT -- SIGNIFICANCE ASSESSMENT -- RECOMMENDATIONS -- Public Health Response -- Policy Review -- Research Regarding MMR and ASD -- Communications -- General and Crosscutting Issues -- SUMMARY -- REFERENCES -- Appendix B Monday, July 16, 2001 Meeting Agenda -- Appendix C Thimerosal Content in Licensed Vaccines -- Appendix D Immunization Safety Review Committee Biosketches -- Board on Health Promotion Disease Prevention Liaison | |
| 650 | 0 | |a Vaccination |x Complications. |0 http://id.loc.gov/authorities/subjects/sh85141710 | |
| 650 | 0 | |a Developmental disabilities |x Etiology. | |
| 650 | 0 | |a Organomercury compounds |x Physiological effect. | |
| 650 | 0 | |a Children. |0 http://id.loc.gov/authorities/subjects/sh85023418 | |
| 650 | 0 | |a Immunization. |0 http://id.loc.gov/authorities/subjects/sh85064545 | |
| 650 | 2 | |a Vaccination |x adverse effects | |
| 650 | 2 | |a Vaccines |x adverse effects | |
| 650 | 2 | |a Neurotoxicity Syndromes |x etiology | |
| 650 | 2 | |a Thimerosal |x toxicity | |
| 650 | 2 | |a Child | |
| 650 | 2 | |a Child Development Disorders, Pervasive |x etiology | |
| 650 | 2 | |a Thimerosal |x adverse effects | |
| 650 | 2 | |a Immunization | |
| 650 | 2 | |a Safety | |
| 650 | 2 | |a Autistic Disorder |x etiology | |
| 650 | 6 | |a Vaccination |x Complications et séquelles. | |
| 650 | 6 | |a Thiomersal |x Effets physiologiques. | |
| 650 | 6 | |a Troubles du développement |x Étiologie. | |
| 650 | 6 | |a Composés organomercuriques |x Effets physiologiques. | |
| 650 | 6 | |a Enfants. | |
| 650 | 6 | |a Immunisation. | |
| 650 | 7 | |a children (people by age group) |2 aat | |
| 650 | 7 | |a MEDICAL |x Preventive Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Forensic Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Public Health. |2 bisacsh | |
| 650 | 7 | |a Immunization |2 fast | |
| 650 | 7 | |a Children |2 fast | |
| 650 | 7 | |a Developmental disabilities |x Etiology |2 fast | |
| 650 | 7 | |a Vaccination |x Complications |2 fast | |
| 653 | |a Andre fag (naturvidenskab og teknik) |a Andre fag | ||
| 655 | 0 | |a Electronic book. | |
| 700 | 1 | |a Stratton, Kathleen R. |0 http://id.loc.gov/authorities/names/n93803579 | |
| 700 | 1 | |a Gable, Alicia. |0 http://id.loc.gov/authorities/names/n2002016399 | |
| 700 | 1 | |a McCormick, Marie C. |0 http://id.loc.gov/authorities/names/n98091060 | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Immunization Safety Review Committee. |0 http://id.loc.gov/authorities/names/n2001130345 | |
| 758 | |i has work: |a Immunization safety review (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGhjBfJBwvdmCh63BYTKtX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Immunization safety review. |d Washington, D.C. : National Academy Press, ©2001 |z 0309076366 |w (DLC) 2002277341 |w (OCoLC)48633600 |
| 830 | 0 | |a Compass series (Washington, D.C.) |0 http://id.loc.gov/authorities/names/n97013362 | |
| 856 | 1 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308 |3 Volltext | |
| 856 | 1 | |l CBO01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308 |3 Volltext | |
| 938 | |a Baker & Taylor |b BKTY |c 30.75 |d 30.75 |i 0309076366 |n 0004018107 |s active | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3377165 | ||
| 938 | |a EBSCOhost |b EBSC |n 121308 | ||
| 938 | |a YBP Library Services |b YANK |n 2293643 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocm57005524 |
|---|---|
| _version_ | 1813903277547323392 |
| adam_text | |
| any_adam_object | |
| author2 | Stratton, Kathleen R. Gable, Alicia McCormick, Marie C. |
| author2_role | |
| author2_variant | k r s kr krs a g ag m c m mc mcm |
| author_GND | http://id.loc.gov/authorities/names/n93803579 http://id.loc.gov/authorities/names/n2002016399 http://id.loc.gov/authorities/names/n98091060 |
| author_corporate | Institute of Medicine (U.S.). Immunization Safety Review Committee |
| author_corporate_role | |
| author_facet | Stratton, Kathleen R. Gable, Alicia McCormick, Marie C. Institute of Medicine (U.S.). Immunization Safety Review Committee |
| author_sort | Stratton, Kathleen R. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RA638 |
| callnumber-raw | RA638 .I648 2001eb |
| callnumber-search | RA638 .I648 2001eb |
| callnumber-sort | RA 3638 I648 42001EB |
| callnumber-subject | RA - Public Medicine |
| collection | ZDB-4-EBA |
| contents | IMMUNIZATION SAFETY REVIEW -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- PLAUSIBILITY ASSESSMENT -- Biological Plausibility -- Causality -- SIGNIFICANCE ASSESSMENT -- PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Research -- Clinical Research -- Basic Science Research -- Communications -- SUMMARY -- REFERENCES -- Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders -- ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT THE CHARGE TO THE COMMITTEETHE STUDY PROCESS -- THE FRAMEWORK FOR ASSESSING CAUSALITY -- UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS -- Thimerosal in Vaccines -- Neurodevelopmental Disorders -- Autism -- Attention Deficit/Hyperactivity Disorder (ADHD) -- Speech or Language Delay -- PLAUSIBILITY ASSESSMENT -- Evidence Regarding Association: Biological Plausibility -- Mercury Toxicokinetics -- Comparisons of Ethylmercury and Methylmercury -- Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury Health Effects of Low-Dose Exposures to Thimerosal and MethylmercuryInvestigations Related to Mercury and Heavy Metals in Children with Autism -- Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines -- Biological Plausibility Argument -- Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies -- Case Reports and Case Series -- Epidemiological Studies -- CAUSALITY ARGUMENT -- SIGNIFICANCE ASSESSMENT -- Concern Regarding Neurodevelopmental Disorders Continued Exposure to ThimerosalUse of Thimerosal-Containing Vaccines in Other Countries -- Confusion from Changes in Hepatitis B Immunization Policy -- Trust in the Safety of Vaccines -- Conclusion -- RECOMMENDATIONS REGARDING THE PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Studies -- Clinical Studies -- Basic Science Studies -- Communications -- SUMMARY -- REFERENCES -- Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary OVERVIEW OF THE IMMUNIZATION SAFETY REVIEW PROJECTTHE HYPOTHESIZED RELATIONSHIP BETWEEN MMR AND AUTISM -- PLAUSIBILITY ASSESSMENT -- SIGNIFICANCE ASSESSMENT -- RECOMMENDATIONS -- Public Health Response -- Policy Review -- Research Regarding MMR and ASD -- Communications -- General and Crosscutting Issues -- SUMMARY -- REFERENCES -- Appendix B Monday, July 16, 2001 Meeting Agenda -- Appendix C Thimerosal Content in Licensed Vaccines -- Appendix D Immunization Safety Review Committee Biosketches -- Board on Health Promotion Disease Prevention Liaison |
| ctrlnum | (OCoLC)57005524 |
| dewey-full | 614.5/98 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 614 - Forensic medicine; incidence of disease |
| dewey-raw | 614.5/98 |
| dewey-search | 614.5/98 |
| dewey-sort | 3614.5 298 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>09556cam a2201105 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm57005524 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240705115654.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu|||unuuu</controlfield><controlfield tag="008">041120s2001 dcuad ob 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MMU</subfield><subfield code="d">BAKER</subfield><subfield code="d">LVB</subfield><subfield code="d">REDDC</subfield><subfield code="d">OCLCE</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">IDEBK</subfield><subfield code="d">COF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">CCO</subfield><subfield code="d">E7B</subfield><subfield code="d">GPM</subfield><subfield code="d">DKDLA</subfield><subfield code="d">NNM</subfield><subfield code="d">SNM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">XFF</subfield><subfield code="d">FVL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UV0</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">LOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFBR</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">NJR</subfield><subfield code="d">OCLCA</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">STF</subfield><subfield code="d">VNS</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">COCUF</subfield><subfield code="d">NRAMU</subfield><subfield code="d">EZ9</subfield><subfield code="d">ICG</subfield><subfield code="d">VT2</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCA</subfield><subfield code="d">G3B</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MERER</subfield><subfield code="d">OCLCO</subfield><subfield code="d">CEF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">ADU</subfield><subfield code="d">KIJ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKCRE</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield><subfield code="d">SFB</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA376785</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">48972074</subfield><subfield code="a">49604899</subfield><subfield code="a">70752236</subfield><subfield code="a">475754481</subfield><subfield code="a">488338610</subfield><subfield code="a">559521597</subfield><subfield code="a">606676038</subfield><subfield code="a">609216218</subfield><subfield code="a">646723489</subfield><subfield code="a">666925644</subfield><subfield code="a">722312199</subfield><subfield code="a">728011803</subfield><subfield code="a">756529205</subfield><subfield code="a">767450788</subfield><subfield code="a">771300093</subfield><subfield code="a">923268733</subfield><subfield code="a">961559357</subfield><subfield code="a">962587840</subfield><subfield code="a">966261309</subfield><subfield code="a">988482525</subfield><subfield code="a">991915290</subfield><subfield code="a">1011897732</subfield><subfield code="a">1017612098</subfield><subfield code="a">1018027318</subfield><subfield code="a">1028767577</subfield><subfield code="a">1037900777</subfield><subfield code="a">1038185333</subfield><subfield code="a">1038668518</subfield><subfield code="a">1044634997</subfield><subfield code="a">1045387444</subfield><subfield code="a">1045485320</subfield><subfield code="a">1047574288</subfield><subfield code="a">1055377160</subfield><subfield code="a">1065042781</subfield><subfield code="a">1103541314</subfield><subfield code="a">1112872373</subfield><subfield code="a">1119150538</subfield><subfield code="a">1119441577</subfield><subfield code="a">1153535487</subfield><subfield code="a">1204384453</subfield><subfield code="a">1228582382</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309565731</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309565738</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309076366</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309076364</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309090083</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309090087</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)57005524</subfield><subfield code="z">(OCoLC)48972074</subfield><subfield code="z">(OCoLC)49604899</subfield><subfield code="z">(OCoLC)70752236</subfield><subfield code="z">(OCoLC)475754481</subfield><subfield code="z">(OCoLC)488338610</subfield><subfield code="z">(OCoLC)559521597</subfield><subfield code="z">(OCoLC)606676038</subfield><subfield code="z">(OCoLC)609216218</subfield><subfield code="z">(OCoLC)646723489</subfield><subfield code="z">(OCoLC)666925644</subfield><subfield code="z">(OCoLC)722312199</subfield><subfield code="z">(OCoLC)728011803</subfield><subfield code="z">(OCoLC)756529205</subfield><subfield code="z">(OCoLC)767450788</subfield><subfield code="z">(OCoLC)771300093</subfield><subfield code="z">(OCoLC)923268733</subfield><subfield code="z">(OCoLC)961559357</subfield><subfield code="z">(OCoLC)962587840</subfield><subfield code="z">(OCoLC)966261309</subfield><subfield code="z">(OCoLC)988482525</subfield><subfield code="z">(OCoLC)991915290</subfield><subfield code="z">(OCoLC)1011897732</subfield><subfield code="z">(OCoLC)1017612098</subfield><subfield code="z">(OCoLC)1018027318</subfield><subfield code="z">(OCoLC)1028767577</subfield><subfield code="z">(OCoLC)1037900777</subfield><subfield code="z">(OCoLC)1038185333</subfield><subfield code="z">(OCoLC)1038668518</subfield><subfield code="z">(OCoLC)1044634997</subfield><subfield code="z">(OCoLC)1045387444</subfield><subfield code="z">(OCoLC)1045485320</subfield><subfield code="z">(OCoLC)1047574288</subfield><subfield code="z">(OCoLC)1055377160</subfield><subfield code="z">(OCoLC)1065042781</subfield><subfield code="z">(OCoLC)1103541314</subfield><subfield code="z">(OCoLC)1112872373</subfield><subfield code="z">(OCoLC)1119150538</subfield><subfield code="z">(OCoLC)1119441577</subfield><subfield code="z">(OCoLC)1153535487</subfield><subfield code="z">(OCoLC)1204384453</subfield><subfield code="z">(OCoLC)1228582382</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="n">Title subscribed to via ProQuest Academic Complete</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">dlr</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA638</subfield><subfield code="b">.I648 2001eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2001 O-342</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WS 135</subfield><subfield code="b">I333 2001</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">076000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">030000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">078000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">614.5/98</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Immunization safety review :</subfield><subfield code="b">thimerosal-containing vaccines and neurodevelopmental disorders /</subfield><subfield code="c">Kathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine.</subfield></datafield><datafield tag="246" ind1="3" ind2="0"><subfield code="a">Thimerosal-containing vaccines and neurodevelopmental disorders</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academy Press,</subfield><subfield code="c">©2001.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiii, 122 pages :)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">The compass series</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="3">Use copy</subfield><subfield code="f">Restrictions unspecified</subfield><subfield code="2">star</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction.</subfield><subfield code="b">[Place of publication not identified] :</subfield><subfield code="c">HathiTrust Digital Library,</subfield><subfield code="d">2010.</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.</subfield><subfield code="u">http://purl.oclc.org/DLF/benchrepro0212</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">digitized</subfield><subfield code="c">2010</subfield><subfield code="h">HathiTrust Digital Library</subfield><subfield code="l">committed to preserve</subfield><subfield code="2">pda</subfield><subfield code="5">MiAaHDL</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">IMMUNIZATION SAFETY REVIEW -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- PLAUSIBILITY ASSESSMENT -- Biological Plausibility -- Causality -- SIGNIFICANCE ASSESSMENT -- PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Research -- Clinical Research -- Basic Science Research -- Communications -- SUMMARY -- REFERENCES -- Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders -- ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">THE CHARGE TO THE COMMITTEETHE STUDY PROCESS -- THE FRAMEWORK FOR ASSESSING CAUSALITY -- UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS -- Thimerosal in Vaccines -- Neurodevelopmental Disorders -- Autism -- Attention Deficit/Hyperactivity Disorder (ADHD) -- Speech or Language Delay -- PLAUSIBILITY ASSESSMENT -- Evidence Regarding Association: Biological Plausibility -- Mercury Toxicokinetics -- Comparisons of Ethylmercury and Methylmercury -- Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Health Effects of Low-Dose Exposures to Thimerosal and MethylmercuryInvestigations Related to Mercury and Heavy Metals in Children with Autism -- Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines -- Biological Plausibility Argument -- Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies -- Case Reports and Case Series -- Epidemiological Studies -- CAUSALITY ARGUMENT -- SIGNIFICANCE ASSESSMENT -- Concern Regarding Neurodevelopmental Disorders</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Continued Exposure to ThimerosalUse of Thimerosal-Containing Vaccines in Other Countries -- Confusion from Changes in Hepatitis B Immunization Policy -- Trust in the Safety of Vaccines -- Conclusion -- RECOMMENDATIONS REGARDING THE PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Studies -- Clinical Studies -- Basic Science Studies -- Communications -- SUMMARY -- REFERENCES -- Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">OVERVIEW OF THE IMMUNIZATION SAFETY REVIEW PROJECTTHE HYPOTHESIZED RELATIONSHIP BETWEEN MMR AND AUTISM -- PLAUSIBILITY ASSESSMENT -- SIGNIFICANCE ASSESSMENT -- RECOMMENDATIONS -- Public Health Response -- Policy Review -- Research Regarding MMR and ASD -- Communications -- General and Crosscutting Issues -- SUMMARY -- REFERENCES -- Appendix B Monday, July 16, 2001 Meeting Agenda -- Appendix C Thimerosal Content in Licensed Vaccines -- Appendix D Immunization Safety Review Committee Biosketches -- Board on Health Promotion Disease Prevention Liaison</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Vaccination</subfield><subfield code="x">Complications.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85141710</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Developmental disabilities</subfield><subfield code="x">Etiology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Organomercury compounds</subfield><subfield code="x">Physiological effect.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Children.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023418</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Immunization.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85064545</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Vaccination</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Vaccines</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Neurotoxicity Syndromes</subfield><subfield code="x">etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Thimerosal</subfield><subfield code="x">toxicity</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Child Development Disorders, Pervasive</subfield><subfield code="x">etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Thimerosal</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Immunization</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Safety</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Autistic Disorder</subfield><subfield code="x">etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Vaccination</subfield><subfield code="x">Complications et séquelles.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Thiomersal</subfield><subfield code="x">Effets physiologiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Troubles du développement</subfield><subfield code="x">Étiologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Composés organomercuriques</subfield><subfield code="x">Effets physiologiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Enfants.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Immunisation.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">children (people by age group)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Preventive Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Forensic Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Public Health.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunization</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Children</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Developmental disabilities</subfield><subfield code="x">Etiology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccination</subfield><subfield code="x">Complications</subfield><subfield code="2">fast</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Andre fag (naturvidenskab og teknik)</subfield><subfield code="a">Andre fag</subfield></datafield><datafield tag="655" ind1=" " ind2="0"><subfield code="a">Electronic book.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stratton, Kathleen R.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n93803579</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gable, Alicia.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2002016399</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McCormick, Marie C.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n98091060</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Immunization Safety Review Committee.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2001130345</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Immunization safety review (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGhjBfJBwvdmCh63BYTKtX</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Immunization safety review.</subfield><subfield code="d">Washington, D.C. : National Academy Press, ©2001</subfield><subfield code="z">0309076366</subfield><subfield code="w">(DLC) 2002277341</subfield><subfield code="w">(OCoLC)48633600</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Compass series (Washington, D.C.)</subfield><subfield code="0">http://id.loc.gov/authorities/names/n97013362</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">CBO01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Baker & Taylor</subfield><subfield code="b">BKTY</subfield><subfield code="c">30.75</subfield><subfield code="d">30.75</subfield><subfield code="i">0309076366</subfield><subfield code="n">0004018107</subfield><subfield code="s">active</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3377165</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">121308</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2293643</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield></record></collection> |
| genre | Electronic book. |
| genre_facet | Electronic book. |
| id | ZDB-4-EBA-ocm57005524 |
| illustrated | Illustrated |
| indexdate | 2024-10-25T16:16:08Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/n2001130345 |
| isbn | 0309565731 9780309565738 |
| language | English |
| oclc_num | 57005524 |
| open_access_boolean | |
| owner | MAIN |
| owner_facet | MAIN |
| physical | 1 online resource (xiii, 122 pages :) |
| psigel | ZDB-4-EBA |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | National Academy Press, |
| record_format | marc |
| series | Compass series (Washington, D.C.) |
| series2 | The compass series |
| spelling | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / Kathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. Thimerosal-containing vaccines and neurodevelopmental disorders Washington, D.C. : National Academy Press, ©2001. 1 online resource (xiii, 122 pages :) text txt rdacontent computer c rdamedia online resource cr rdacarrier data file The compass series Includes bibliographical references. Print version record. Use copy Restrictions unspecified star MiAaHDL Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2010. MiAaHDL Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL IMMUNIZATION SAFETY REVIEW -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- PLAUSIBILITY ASSESSMENT -- Biological Plausibility -- Causality -- SIGNIFICANCE ASSESSMENT -- PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Research -- Clinical Research -- Basic Science Research -- Communications -- SUMMARY -- REFERENCES -- Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders -- ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT THE CHARGE TO THE COMMITTEETHE STUDY PROCESS -- THE FRAMEWORK FOR ASSESSING CAUSALITY -- UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS -- Thimerosal in Vaccines -- Neurodevelopmental Disorders -- Autism -- Attention Deficit/Hyperactivity Disorder (ADHD) -- Speech or Language Delay -- PLAUSIBILITY ASSESSMENT -- Evidence Regarding Association: Biological Plausibility -- Mercury Toxicokinetics -- Comparisons of Ethylmercury and Methylmercury -- Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury Health Effects of Low-Dose Exposures to Thimerosal and MethylmercuryInvestigations Related to Mercury and Heavy Metals in Children with Autism -- Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines -- Biological Plausibility Argument -- Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies -- Case Reports and Case Series -- Epidemiological Studies -- CAUSALITY ARGUMENT -- SIGNIFICANCE ASSESSMENT -- Concern Regarding Neurodevelopmental Disorders Continued Exposure to ThimerosalUse of Thimerosal-Containing Vaccines in Other Countries -- Confusion from Changes in Hepatitis B Immunization Policy -- Trust in the Safety of Vaccines -- Conclusion -- RECOMMENDATIONS REGARDING THE PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Studies -- Clinical Studies -- Basic Science Studies -- Communications -- SUMMARY -- REFERENCES -- Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary OVERVIEW OF THE IMMUNIZATION SAFETY REVIEW PROJECTTHE HYPOTHESIZED RELATIONSHIP BETWEEN MMR AND AUTISM -- PLAUSIBILITY ASSESSMENT -- SIGNIFICANCE ASSESSMENT -- RECOMMENDATIONS -- Public Health Response -- Policy Review -- Research Regarding MMR and ASD -- Communications -- General and Crosscutting Issues -- SUMMARY -- REFERENCES -- Appendix B Monday, July 16, 2001 Meeting Agenda -- Appendix C Thimerosal Content in Licensed Vaccines -- Appendix D Immunization Safety Review Committee Biosketches -- Board on Health Promotion Disease Prevention Liaison Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Developmental disabilities Etiology. Organomercury compounds Physiological effect. Children. http://id.loc.gov/authorities/subjects/sh85023418 Immunization. http://id.loc.gov/authorities/subjects/sh85064545 Vaccination adverse effects Vaccines adverse effects Neurotoxicity Syndromes etiology Thimerosal toxicity Child Child Development Disorders, Pervasive etiology Thimerosal adverse effects Immunization Safety Autistic Disorder etiology Vaccination Complications et séquelles. Thiomersal Effets physiologiques. Troubles du développement Étiologie. Composés organomercuriques Effets physiologiques. Enfants. Immunisation. children (people by age group) aat MEDICAL Preventive Medicine. bisacsh MEDICAL Forensic Medicine. bisacsh MEDICAL Public Health. bisacsh Immunization fast Children fast Developmental disabilities Etiology fast Vaccination Complications fast Andre fag (naturvidenskab og teknik) Andre fag Electronic book. Stratton, Kathleen R. http://id.loc.gov/authorities/names/n93803579 Gable, Alicia. http://id.loc.gov/authorities/names/n2002016399 McCormick, Marie C. http://id.loc.gov/authorities/names/n98091060 Institute of Medicine (U.S.). Immunization Safety Review Committee. http://id.loc.gov/authorities/names/n2001130345 has work: Immunization safety review (Text) https://id.oclc.org/worldcat/entity/E39PCGhjBfJBwvdmCh63BYTKtX https://id.oclc.org/worldcat/ontology/hasWork Print version: Immunization safety review. Washington, D.C. : National Academy Press, ©2001 0309076366 (DLC) 2002277341 (OCoLC)48633600 Compass series (Washington, D.C.) http://id.loc.gov/authorities/names/n97013362 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308 Volltext CBO01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308 Volltext |
| spellingShingle | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / Compass series (Washington, D.C.) IMMUNIZATION SAFETY REVIEW -- Copyright -- Acknowledgments -- Contents -- Executive Summary -- PLAUSIBILITY ASSESSMENT -- Biological Plausibility -- Causality -- SIGNIFICANCE ASSESSMENT -- PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Research -- Clinical Research -- Basic Science Research -- Communications -- SUMMARY -- REFERENCES -- Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders -- ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT THE CHARGE TO THE COMMITTEETHE STUDY PROCESS -- THE FRAMEWORK FOR ASSESSING CAUSALITY -- UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS -- Thimerosal in Vaccines -- Neurodevelopmental Disorders -- Autism -- Attention Deficit/Hyperactivity Disorder (ADHD) -- Speech or Language Delay -- PLAUSIBILITY ASSESSMENT -- Evidence Regarding Association: Biological Plausibility -- Mercury Toxicokinetics -- Comparisons of Ethylmercury and Methylmercury -- Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury Health Effects of Low-Dose Exposures to Thimerosal and MethylmercuryInvestigations Related to Mercury and Heavy Metals in Children with Autism -- Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines -- Biological Plausibility Argument -- Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies -- Case Reports and Case Series -- Epidemiological Studies -- CAUSALITY ARGUMENT -- SIGNIFICANCE ASSESSMENT -- Concern Regarding Neurodevelopmental Disorders Continued Exposure to ThimerosalUse of Thimerosal-Containing Vaccines in Other Countries -- Confusion from Changes in Hepatitis B Immunization Policy -- Trust in the Safety of Vaccines -- Conclusion -- RECOMMENDATIONS REGARDING THE PUBLIC HEALTH RESPONSE -- Policy Review and Analysis -- Public Health and Biomedical Research -- Epidemiological Studies -- Clinical Studies -- Basic Science Studies -- Communications -- SUMMARY -- REFERENCES -- Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary OVERVIEW OF THE IMMUNIZATION SAFETY REVIEW PROJECTTHE HYPOTHESIZED RELATIONSHIP BETWEEN MMR AND AUTISM -- PLAUSIBILITY ASSESSMENT -- SIGNIFICANCE ASSESSMENT -- RECOMMENDATIONS -- Public Health Response -- Policy Review -- Research Regarding MMR and ASD -- Communications -- General and Crosscutting Issues -- SUMMARY -- REFERENCES -- Appendix B Monday, July 16, 2001 Meeting Agenda -- Appendix C Thimerosal Content in Licensed Vaccines -- Appendix D Immunization Safety Review Committee Biosketches -- Board on Health Promotion Disease Prevention Liaison Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Developmental disabilities Etiology. Organomercury compounds Physiological effect. Children. http://id.loc.gov/authorities/subjects/sh85023418 Immunization. http://id.loc.gov/authorities/subjects/sh85064545 Vaccination adverse effects Vaccines adverse effects Neurotoxicity Syndromes etiology Thimerosal toxicity Child Child Development Disorders, Pervasive etiology Thimerosal adverse effects Immunization Safety Autistic Disorder etiology Vaccination Complications et séquelles. Thiomersal Effets physiologiques. Troubles du développement Étiologie. Composés organomercuriques Effets physiologiques. Enfants. Immunisation. children (people by age group) aat MEDICAL Preventive Medicine. bisacsh MEDICAL Forensic Medicine. bisacsh MEDICAL Public Health. bisacsh Immunization fast Children fast Developmental disabilities Etiology fast Vaccination Complications fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85141710 http://id.loc.gov/authorities/subjects/sh85023418 http://id.loc.gov/authorities/subjects/sh85064545 |
| title | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / |
| title_alt | Thimerosal-containing vaccines and neurodevelopmental disorders |
| title_auth | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / |
| title_exact_search | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / |
| title_full | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / Kathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. |
| title_fullStr | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / Kathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. |
| title_full_unstemmed | Immunization safety review : thimerosal-containing vaccines and neurodevelopmental disorders / Kathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. |
| title_short | Immunization safety review : |
| title_sort | immunization safety review thimerosal containing vaccines and neurodevelopmental disorders |
| title_sub | thimerosal-containing vaccines and neurodevelopmental disorders / |
| topic | Vaccination Complications. http://id.loc.gov/authorities/subjects/sh85141710 Developmental disabilities Etiology. Organomercury compounds Physiological effect. Children. http://id.loc.gov/authorities/subjects/sh85023418 Immunization. http://id.loc.gov/authorities/subjects/sh85064545 Vaccination adverse effects Vaccines adverse effects Neurotoxicity Syndromes etiology Thimerosal toxicity Child Child Development Disorders, Pervasive etiology Thimerosal adverse effects Immunization Safety Autistic Disorder etiology Vaccination Complications et séquelles. Thiomersal Effets physiologiques. Troubles du développement Étiologie. Composés organomercuriques Effets physiologiques. Enfants. Immunisation. children (people by age group) aat MEDICAL Preventive Medicine. bisacsh MEDICAL Forensic Medicine. bisacsh MEDICAL Public Health. bisacsh Immunization fast Children fast Developmental disabilities Etiology fast Vaccination Complications fast |
| topic_facet | Vaccination Complications. Developmental disabilities Etiology. Organomercury compounds Physiological effect. Children. Immunization. Vaccination adverse effects Vaccines adverse effects Neurotoxicity Syndromes etiology Thimerosal toxicity Child Child Development Disorders, Pervasive etiology Thimerosal adverse effects Immunization Safety Autistic Disorder etiology Vaccination Complications et séquelles. Thiomersal Effets physiologiques. Troubles du développement Étiologie. Composés organomercuriques Effets physiologiques. Enfants. Immunisation. children (people by age group) MEDICAL Preventive Medicine. MEDICAL Forensic Medicine. MEDICAL Public Health. Children Developmental disabilities Etiology Vaccination Complications Electronic book. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308 |
| work_keys_str_mv | AT strattonkathleenr immunizationsafetyreviewthimerosalcontainingvaccinesandneurodevelopmentaldisorders AT gablealicia immunizationsafetyreviewthimerosalcontainingvaccinesandneurodevelopmentaldisorders AT mccormickmariec immunizationsafetyreviewthimerosalcontainingvaccinesandneurodevelopmentaldisorders AT instituteofmedicineusimmunizationsafetyreviewcommittee immunizationsafetyreviewthimerosalcontainingvaccinesandneurodevelopmentaldisorders AT strattonkathleenr thimerosalcontainingvaccinesandneurodevelopmentaldisorders AT gablealicia thimerosalcontainingvaccinesandneurodevelopmentaldisorders AT mccormickmariec thimerosalcontainingvaccinesandneurodevelopmentaldisorders AT instituteofmedicineusimmunizationsafetyreviewcommittee thimerosalcontainingvaccinesandneurodevelopmentaldisorders |